Krishna Talluri
Overview
Explore the profile of Krishna Talluri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simpkins C, Moncure M, Klepacz H, Roach K, Benzaquen S, Diaz-Caballero L, et al.
EClinicalMedicine
. 2024 Mar;
68:102430.
PMID: 38545092
Background: Since the 1990's attempts to favorably modulate nitric oxide (NO) have been unsuccessful. We hypothesized that because NO is lipophilic it would preferentially localize into intravascularly infused hydrophobic nanoparticles,...
2.
Bernard J, Salaun E, Padmanabhan C, Deja M, Hote M, Choudhary S, et al.
EuroIntervention
. 2022 Aug;
18(10):836-839.
PMID: 35950967
No abstract available.
3.
Talluri K, Lall N, Moreno M, Nichols L, Bande D
Cureus
. 2021 Mar;
13(2):e13475.
PMID: 33777563
As the world has struggled to adapt to the coronavirus disease (COVID-19) pandemic, new evidence has emerged suggesting that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may manifest with...
4.
Simpkins C, Talluri K, Williams M
Mil Med
. 2016 May;
181(5 Suppl):253-8.
PMID: 27168581
Objective: The following were studied in a perimortem mouse model of rapid blood loss: (a) efficacy of a prototypical micellar colloid, Intralipid 20%, (IL20), compared to albumin (b) comparison of...
5.
Begley C, Shegog R, Iyagba B, Chen V, Talluri K, Dubinsky S, et al.
Epilepsy Behav
. 2010 Oct;
19(3):232-8.
PMID: 20884301
We compared the scores on self-management and associated psychosocial scales of patients with epilepsy at two clinics in Houston, TX, USA, to determine if there were systematic differences associated with...
6.
Berwaerts J, Cleton A, Rossenu S, Talluri K, Remmerie B, Janssens L, et al.
J Psychopharmacol
. 2009 Oct;
24(7):1011-8.
PMID: 19825908
Increases in serum prolactin concentrations after administration of risperidone have been attributed, by some, to the availability of paliperidone in plasma. This double-blind, randomized, parallel-group study in patients with schizophrenia...
7.
Boom S, Talluri K, Janssens L, Remmerie B, De Meulder M, Rossenu S, et al.
J Clin Pharmacol
. 2009 Aug;
49(11):1318-30.
PMID: 19713555
Paliperidone extended-release tablet (paliperidone ER) is a centrally active dopamine D(2)- and serotonergic 5-HT(2A)-receptor antagonist that is registered for the treatment of schizophrenia. The controlled rate of release of paliperidone...
8.
Thyssen A, Cleton A, Talluri K, Leempoels J, Janssens L, Boom S, et al.
Hum Psychopharmacol
. 2009 Aug;
24(7):532-9.
PMID: 19693799
Objective: The effect of trimethoprim, a potent organic cation transport inhibitor, on the pharmacokinetics (PK) of paliperidone extended-release tablets (paliperidone ER), an organic cation mainly eliminated via renal excretion, was...
9.
Vermeir M, Naessens I, Remmerie B, Mannens G, Hendrickx J, Sterkens P, et al.
Drug Metab Dispos
. 2008 Jan;
36(4):769-79.
PMID: 18227146
Absorption, metabolism, and excretion of paliperidone, an atypical antipsychotic, was studied in five healthy male subjects after a single dose of 1 mg of [(14)C]paliperidone oral solution ( approximately 16...
10.
Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, et al.
Int Clin Psychopharmacol
. 2007 Aug;
22(5):299-308.
PMID: 17690599
The effects of paliperidone extended-release on sleep architecture in patients with schizophrenia-related insomnia were evaluated in this multicenter, double-blind, randomized, placebo-controlled study. Patients received paliperidone extended-release 9 mg/day or matching...